METASTATIC MALIGNANT-MELANOMA WITH RHABDOID FEATURES

被引:61
|
作者
CHANG, ES [1 ]
WICK, MR [1 ]
SWANSON, PE [1 ]
DEHNER, LP [1 ]
机构
[1] WASHINGTON UNIV, BARNES HOSP,MED CTR,DIV SURG PATHOL, LAUREN V ACKERMAN LAB SURG PATHOL, ST LOUIS, MO 63110 USA
关键词
IMMUNOHISTOLOGY; INTERMEDIATE FILAMENT PROTEINS; MALIGNANT MELANOMA; RHABDOID TUMOR;
D O I
10.1093/ajcp/102.4.426
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The authors propose the addition of malignant melanoma to the list of extrarenal neoplasms that may be predominantly composed of polygonal cells with the cytologic features of ''rhabdoid'' tumor. A review of 313 metastatic melanomas disclosed 49 examples with rhabdoid features, from which 31 had sufficient material for further pathologic and immunohistologic characterization. A control group of 46 nonrhabdoid metastatic melanomas was examined in parallel fashion. In 39% of cases, rhabdoid melanomas manifested relative deletion of S100 protein compared with the control tumors. However, there were no differences in staining with HMB-45. Vimentin immunoreactivity was concentrated in the paranuclear cytoplasm of rhabdoid melanoma cells. However, ultrastructural studies of these cases failed to show correspending whorls of intermediate filaments and instead demonstrated paracrystalline paranuclear inclusions in profiles of rough endoplasmic reticulum. It is concluded that metastatic rhabdoid melanoma exhibits significant morphologic similarity to other rhabdoid tumors at a light-microscopic level. However, it usually retains enough melanocytic attributes to allow for accurate diagnostic recognition. Probably because patients with metastatic melanoma have an extremely poor prognosis overall, no worsening of biologic behavior was associated with rhabdoid cytomorphologic findings in this tumor type when compared with the control cases.
引用
收藏
页码:426 / 431
页数:6
相关论文
共 50 条
  • [31] DERMATOMYOSITIS IN A PATIENT WITH MALIGNANT-MELANOMA
    GRUBERG, L
    LANGEVITZ, P
    LEVARTOWSKY, D
    PRAS, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1994, 12 (03) : 321 - 323
  • [32] CLINICAL-SIGNIFICANCE OF SERUM S100 IN METASTATIC MALIGNANT-MELANOMA
    GUO, HB
    STOFFELWAGNER, B
    BIERWIRTH, T
    MEZGER, J
    KLINGMULLER, D
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (06) : 924 - 928
  • [33] PULMONARY METASTASES OF MALIGNANT-MELANOMA
    DELAUNAY, MM
    AMICI, JM
    GENIAUX, M
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1991, 118 (04): : 307 - 314
  • [34] MALIGNANT-MELANOMA IN EPILUMINESCENT MICROSCOPY
    SCHULZ, H
    HAUTARZT, 1994, 45 (01): : 15 - 19
  • [35] ISOLATION PERFUSION IN MALIGNANT-MELANOMA
    HOHENBERGER, W
    MEYER, T
    GOHL, J
    CHIRURG, 1994, 65 (03): : 175 - 185
  • [36] OSTEOGENIC MELANOMA - A RARE VARIANT OF MALIGNANT-MELANOMA
    LUCAS, DR
    TAZELAAR, HD
    UNNI, KK
    WOLD, LE
    OKADA, K
    DIMARZIO, DJ
    ROLFE, B
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (04) : 400 - 409
  • [37] SUCCESSFUL REMOVAL OF SOLITARY METASTATIC CEREBRAL MALIGNANT-MELANOMA - CASE-REPORT
    DOLAN, RA
    SURGICAL NEUROLOGY, 1993, 39 (06): : 466 - 468
  • [38] BRAIN METASTASES OF METASTATIC MALIGNANT-MELANOMA - RESPONSE TO DTIC AND INTERFERON-GAMMA
    SCHADENDORF, D
    WORM, M
    CZARNETZKI, BM
    JOURNAL OF NEURO-ONCOLOGY, 1993, 16 (01) : 77 - 79
  • [39] PROGNOSTIC FACTORS IN METASTATIC MALIGNANT-MELANOMA TREATED WITH COMBINED RADIATION-THERAPY AND HYPERTHERMIA
    BENYOSEF, R
    KAPP, DS
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1993, 9 (06) : 767 - 781
  • [40] IMMUNOTHERAPY IN MALIGNANT-MELANOMA - NEW PERSPECTIVES
    HEBBAR, M
    VANLEMMENS, L
    LECOMTE, S
    BONNETERRE, J
    REVUE DE MEDECINE INTERNE, 1995, 16 (04): : 260 - 270